Institutional Exposure To NewAmsterdam Pharma Company NV (NAMS)
NewAmsterdam Pharma Company NV (NAMS) concluded trading on Thursday at a closing price of $16.53, with 3.27 million shares of worth about $54.13 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -23.29% during that period and on August 22, 2024 the price saw […]
Value Hunters: Look To NewAmsterdam Pharma Company NV (NAMS)
Viking Global Investors LP recently announced the acquisition of new stake in NewAmsterdam Pharma Company NV (NASDAQ:NAMS). The institutional investor has increased its shareholding in the Healthcare company by 22.99% to 8.02 million shares with purchase of 1.5 million shares. This fresh investment now brings its stake to 9.75% valued currently at $89.63 million. In […]
